IP Verse

Mesenchymal Stem Cells And Uses Therefor - EP2298862

The patent EP2298862 was granted to Mesoblast on Aug 30, 2017. The application was originally filed on Mar 15, 2005 under application number EP10011224A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2298862

MESOBLAST
Application Number
EP10011224A
Filing Date
Mar 15, 2005
Status
Opposition Rejected
Feb 14, 2020
Grant Date
Aug 30, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FRIEDRICHMay 30, 2018BREUER FRIEDRICH HAHNER PATENTANWALTE PARTG MBBADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5486359
DESCRIPTIONUS6355239
OPPOSITIONWO2008042174
OPPOSITIONWO9951247
OPPOSITIONWO9951275
SEARCHCN1536075
SEARCHWO03004661
SEARCHWO03059276
SEARCHWO2004006942
SEARCHWO2004011621
SEARCHWO2004084950

Non-Patent Literature (NPL) Citations (65) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BALLAS ET AL., J. CELL. BIOCHEM. SUPPL., (2002), vol. 38, page 20-
DESCRIPTION- BARTHOLOMEW ET AL., EXP. HEMATOL., (2002), vol. 30, page 42-
DESCRIPTION- CHOPP ET AL., NEUROREPORT, (2000), vol. 11, page 3001-
DESCRIPTION- DEKOK ET AL., CLIN. ORAL IMPLANTS RES., (2003), vol. 14, page 481-
DESCRIPTION- DENICOLA ET AL., BLOOD, (2002), vol. 99, page 3838-
DESCRIPTION- DEVINE ET AL., CANCER J., (2001), vol. 7, page 576-
DESCRIPTION- DINICOLA ET AL., BLOOD, (2002), vol. 99, page 3838-
DESCRIPTION- DZIONEK, J. IMMUNOL., (2000), vol. 165, page 6037-
DESCRIPTION- EAVES ET AL., ANN. N.Y. ACAD. SCI., (2001), vol. 938, page 63-
DESCRIPTION- FAKUDA, ARTIF. ORGANS., (2001), vol. 25, page 187-
DESCRIPTION- HARRIS ET AL., TRENDS IMMUNOL., (2002), vol. 23, page 144-
DESCRIPTION- HAYNESWORTH ET AL., BONE, (1992), vol. 13, page 69-
DESCRIPTION- HAYNESWORTH ET AL., J. CELL. PHYSIO, (1996), vol. 166, page 585-
DESCRIPTION- HOROWITZ ET AL., PROC. NAT. ACAD. SCI., (2002), vol. 99, page 8932-
DESCRIPTION- HORWITZ ET AL., BLOOD, (2001), vol. 97, page 1227-
DESCRIPTION- KINGSLEY ET AL., J. IMMUNOL., (2002), vol. 168, page 1080-
DESCRIPTION- KOC ET AL., J. CLIN. ONCOL., (2000), vol. 18, page 307-
DESCRIPTION- LE BLANC ET AL., EXP. HEMATOL., (2003), vol. 31, page 890-
DESCRIPTION- LEBLANC ET AL., EXP. HEMATOL., (2003), vol. 31, page 890-
DESCRIPTION- LEBLANC ET AL., SCAND J. IMMUNOL., (2003), vol. 57, page 11-
DESCRIPTION- LEBLANC ET AL., SCAND. J. IMMUNOL., (2003), vol. 57, page 11-
DESCRIPTION- MACKENZIE ET AL., BLOOD CELLS MOL. DIS., (2002), vol. 27-
DESCRIPTION- MAJUMDAR ET AL., HEMATOTHER. STEM CELL RES., (2000), vol. 9, page 841-
DESCRIPTION- MAJUMDAR ET AL., J. BIOMED. SCI., (2003), vol. 10, page 228-
DESCRIPTION- NOEL ET AL., CURR. OPIN. LNVESTIQ. DRUOS, (2002), vol. 3, page 1000-
DESCRIPTION- PEREIRA ET AL., PROC. NAT. ACAD. SCI., (1998), vol. 95, page 1142-
DESCRIPTION- PITTENGER ET AL., SCIENCE, (1999), vol. 284, page 143-
DESCRIPTION- POTIAN ET AL., J. IMMUNOL., (2003), vol. 171, page 3426-
DESCRIPTION- PROCKOP, SCIENCE, (1997), vol. 276, page 71-
DESCRIPTION- SANCHEZ-RAMOS ET AL., EXP. NEUROL., (2001), vol. 171, page 109-
DESCRIPTION- SCHWARTZ ET AL., HUM. GENE THER., (1999), vol. 10, page 2539-
DESCRIPTION- SHAKE ET AL., ANN. THORAC. SURG., (2002), vol. 73, page 1919-
DESCRIPTION- TOMA ET AL., CIRCULATION, (2002), vol. 105, page 93-
DESCRIPTION- TOMITA ET AL., CIRCULATION, (1999), vol. 100, page 247-
DESCRIPTION- TSE ET AL., TRANSPLANTATION, (2003), vol. 75, page 389-
DESCRIPTION- VASSILIOU ET AL., CELL. IMMUNOL, (2003), vol. 223, page 120-
DESCRIPTION- WAGERS ET AL., GENE THERAPY., (2002), vol. 9, page 606-
DESCRIPTION- WAKITANI ET AL., MUSCLE NERVE, (1995), vol. 18, page 1417-
DESCRIPTION- WOODBURY ET AL., J. NEUROSCI. RES., (2002), vol. 69, page 908-
DESCRIPTION- WU ET AL., J. NEUROSCI. RES., (2003), vol. 72, page 393-
DESCRIPTION- WU ET AL., TRANSPLANTATION, (2003), vol. 75, page 679-
OPPOSITION- GOR et al., "TH 1- TH 2: a procrustean paradigm", Nat Immunol, (20030600), vol. 4, no. 6, pages 503 - 505, XP055496542-
OPPOSITION- ISHIDA et al., "Requirement of Donor-Derived Stromal Cells in the Bone Marrow for Successful Allogeneic Bone Marrow Transplantation", J Immunol., (19940315), vol. 152, no. 6, pages 3119 - 27, XP055496512-
OPPOSITION- JORGENSEN et al., "105 Immunosuppressive effect of mesenchymal stem cells in collagen-induced arthritis", Arthritis Res Ther, (20030000), vol. 5, no. 3, page S33, XP055496436-
OPPOSITION- JORGENSEN et al., "Mesenchymal stem cells and rheumatoid arthritis", Joint Bone Spine, (20031200), vol. 70, no. 6, pages 483 - 485, XP009145230-
OPPOSITION- RASMUSSON et al., "P431 Human mesenchymal stem cells increase interleukin-2 and soluble IL -2 receptor in mixed lymphocyte cultures", Bone Marrow Transplant, (20040301), vol. 33, page S87, XP055496529-
OPPOSITION- ROSLONIEC et al., "Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity", Arthritis Res, (20020000), vol. 4, no. 6, pages 333 - 336, XP055496544-
OPPOSITION- BARRY, "Biology and clinical applications of mesenchymal stem cells", Birth Defects Res C Embryo Today, (20030800), vol. 93, pages 250 - 256, XP002976497
OPPOSITION- MAJUMDAR et al., "Characterization and Functionality of Cell Surface Molecules on Human Mesenchymal Stem Cells", J. Biomed Sci, (20030000), vol. 10, pages 228 - 241, XP009164891
OPPOSITION- GARCIA-OLMO et al., "Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell -based therapy", Int J Colorectal Dis, (20030901), vol. 18, no. 5, pages 451 - 454, XP002359162
OPPOSITION- JIN et al., "Bone marrow cells promote TH 2 polarization and inhibit virus-specific CTL generation", Hum Immunol, (20001200), vol. 61, no. 12, pages 1233 - 1241, XP055496534
OPPOSITION- DEANS et al., "Mesenchymal stem cells: Biology and potential clinical uses", Experimental Hematology, (20000000), vol. 28, pages 875 - 884, XP002201188
OPPOSITION- BARTHOLOMEW et al., "Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo", Experimental Hematology, (20020101), vol. 30, no. 1, pages 42 - 48, XP008075907
OPPOSITION- HESHMATI, "Mechanisms of action of extracorporeal photochemotherapy", Transfusion and Apheresis Science, (20030800), vol. 29, pages 61 - 70, XP002977587
OPPOSITION- BACIGALUPO et al., "Management of acute graft versus host disease (GvHD)", Hematol J., (20040000), vol. 5, no. 3, pages 189 - 196, XP055496392
OPPOSITION- LE BLANC, "Immunomodulatory effects of fetal and adult mesenchymal stem cells", Cytotherapy, (20030000), vol. 5, no. 6, pages 485 - 489, XP008075543
OPPOSITION- LERNMARK, "Autoimmune diseases: are markers ready for prediction?", J Clin Invest, (20011000), vol. 108, no. 8, pages 1091 - 1096, XP055496556
OPPOSITION- KRAMPERA et al., "Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide", Blood, (20030000), vol. 101, no. 9, pages 3722 - 3729, XP055496530
OPPOSITION- DJOUAD et al., "Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals", Blood, (20031115), vol. 102, no. 10, pages 3837 - 3844, XP002468564
OPPOSITION- AGGARWAL et al., "Human mesenchymal stem cells modulate allogeneic immune cell responses", Blood, (20050000), vol. 105, no. 4, pages 1815 - 1822, XP002422936
OPPOSITION- KUSHIDA et al., "Crucial Role of Donor-Derived Stromal Cells in Successful Treatment for Intractable Autoimmune Diseases in MRL/lpr Mice by BMT Via Portal Vein", Stem Cells, (20010500), vol. 19, pages 226 - 235, XP055496514
OPPOSITION- MAI et al., "T Helper 17 Cells Interplay with CD 4+ CD 25highFoxp3+ Tregs in Regulation of Inflammations and Autoimmune Diseases", NIH Public Access Author Manuscript, (20110601), vol. 15, pages 1 - 28, XP055496552
OPPOSITION- FILACI et al., "Impairment of CD 81 T Suppressor Cell Function in Patients with Active Systemic Lupus Erythematosus", J Immunol, (20010000), vol. 166, pages 6452 - 6457, XP055496519
SEARCH- EL-BADRI NAGWA S; MAHESHWARI AKHIL; SANBERG PAUL R, "Mesenchymal stem cells in autoimmune disease", STEM CELLS AND DEVELOPMENT, (200410), vol. 13, pages 463 - 472, XP009145234 [XP] 1-11 * whole document esp. abstract and page 465 *-
SEARCH- JORGENSEN CHRISTIAN; DJOUAD FARIDA; FRITZ VANESSA; APPARAILLY FLORENCE; PLENCE PASCALE; NOËL DANIELLE, "Mesenchymal stem cells and rheumatoid arthritis", JOINT, BONE, SPINE : REVUE DU RHUMATISME, (200312), vol. 70, no. 6, pages 483 - 485, XP009145230 [X] 1-11 * whole document esp. abstract and pages 484-485 *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents